vimarsana.com

Latest Breaking News On - Kennethw mahaffey - Page 1 : vimarsana.com

How would eliminating race-based adjustments in estimates of kidney function impact clinical trials

Highlights In an analysis of data from a recent clinical trial, researchers found that removing a race-based adjustment in the estimation of

University-of-washington
Washington
United-states
Canada
American
Canadian
Astra-zeneca
Kennethw-mahaffey
Eli-lilly
Megj-jardine
George-bakris
Davidm-charytan

VOLTA MEDICAL raises 28 million USD to revolutionize persistent AFib ablation

Press release content from PR Newswire. The AP news staff was not involved in its creation. VOLTA MEDICAL raises 28 million USD to revolutionize persistent AFib ablation January 5, 2021 GMT Volta Medical logo MARSEILLE, France, Jan. 5, 2021 /PRNewswire/ Volta Medical, a pioneering French-based HealthTech startup, working on novel artificial intelligence (AI) algorithms to treat cardiac arrythmias, today announced that it has successfully raised 28 million USD. The financing round was led by Gilde Healthcare with participation of existing shareholder Pasteur Mutualité. The new capital will allow the company to establish its revolutionary FDA-cleared and CE marked VX1 AI software solution as a new standard of care, pursue further R&D activities and start to roll out commercial activities across the US and Europe. Recruitment for TAILORED-AF, an international multicenter trial has already started. Volta Medical will be welcoming two new Board members. Janke Dittmer, General Partn

United-kingdom
United-states
France
America
Janke-dittmer
Kennethw-mahaffey
Lauren-cheung
Amol-rajmane
Andream-russo
Todd-ferris
Pasteur-mutualit
Marcov-perez

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.